By combining the measurements of HE4 and CA-125, clinicians can calculate the Risk of Ovarian Malignancy Algorithm (ROMA) score. These advancements aim to catch the disease earlier and provide a clearer picture of the cancer's aggressiveness.
Understanding the Ovarian Cancer Early Detection ROMA Score
A high ROMA score can signal the need for a prompt referral to a gynecologic oncologist, while a low score can help reassure a patient and her doctor that immediate, invasive testing may not be necessary. Interpreting Results in Context Because of the limitations of CA-125, healthcare providers look at the result within a broader clinical context.
Many benign conditions, such as endometriosis, uterine fibroids, or even severe menstrual cramping, can also raise these levels. This dynamic interpretation helps distinguish between harmless fluctuations and a potential pathological process.
Understanding the Ovarian Cancer Early Detection ROMA Score
The Cornerstone Test: CA-125 Blood Assay The most recognized ovarian cancer lab test is the CA-125 blood assay. However, it is crucial to understand that an elevated CA-125 level is not synonymous with cancer.
More About Ovarian cancer lab tests
Looking at Ovarian cancer lab tests from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Ovarian cancer lab tests can make the topic easier to follow by connecting earlier points with a few simple takeaways.
